Polycystic Kidney Disease Resource and Translation Center
Kansas PKD Research and Translation Core Center
['FUNDING_OTHER'] · UNIVERSITY OF KANSAS MEDICAL CENTER · NIH-11232060
This center builds and shares tools, lab models, and clinical resources to speed new treatments for adults with autosomal dominant polycystic kidney disease (ADPKD).
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KANSAS MEDICAL CENTER (nih funded) |
| Locations | 1 site (KANSAS CITY, UNITED STATES) |
| Trial ID | NIH-11232060 on ClinicalTrials.gov |
What this research studies
From a patient perspective, this center brings together labs and clinics to create and share key materials like antibodies, animal and cell models, and clinical data to help scientists move discoveries toward care. It is organized into cores that handle antibody/vector production, mouse and cell model support, and clinical/translation activities, plus a new resource development core to create emerging tools. The center supports collaborations across institutions and with community stakeholders so research findings can more quickly lead to clinical studies. Many of the center's services are intended to be available to investigators nationwide, helping speed the path from bench to bedside.
Who could benefit from this research
Good fit: Adults with autosomal dominant polycystic kidney disease who are willing to provide clinical information or biological samples, or to consider participation in future clinical studies, would be the most relevant candidates.
Not a fit: People without ADPKD, or those seeking immediate clinical benefit rather than contributing to research infrastructure, are unlikely to see direct benefits from this center's activities.
Why it matters
Potential benefit: If successful, this center could speed the development of new diagnostics and treatments and expand clinical trial opportunities for people with ADPKD.
How similar studies have performed: Other NIH-funded PKD core centers have a track record of supporting discoveries and enabling clinical trials, so this shared-core approach has precedent.
Where this research is happening
KANSAS CITY, UNITED STATES
- UNIVERSITY OF KANSAS MEDICAL CENTER — KANSAS CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WALLACE, DARREN P. — UNIVERSITY OF KANSAS MEDICAL CENTER
- Study coordinator: WALLACE, DARREN P.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease